Vimarsana
Biggest News Aggregation in the World

Page 2 - Breakthrough Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Designation Today - Breaking & Trending Today

Pfizer (PFE) Q1 2024 Earnings Call Transcript - Vimarsana News

Pfizer (PFE) Q1 2024 Earnings Call Transcript

PFE earnings call for the period ending March 31, 2024.

Source: yahoo.com
Earnings rise 44pc at pharmaceutical services firm Hvivo - Vimarsana News

Earnings rise 44pc at pharmaceutical services firm Hvivo

Pharmaceutical services firm Hvivo, formerly Open Orphan, reported a 44pc rise in earnings in 2023 in a “record year across all financial and operational metrics.”

Is 2024 the Year for Psychedelic Medicine? - Vimarsana News

Is 2024 the Year for Psychedelic Medicine?

MDMA-assisted therapy and psilocybin currently lead the way with potential approvals by the FDA.

Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights - Vimarsana News

Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights

SUZHOU, China, March 29, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2023 and

Alphamab Oncology Announces the First Patient Dosed in Australia in the Clinical Study of Subcutaneous Formulation JSKN033 - Vimarsana News

Alphamab Oncology Announces the First Patient Dosed in Australia in the Clinical Study of Subcutaneous Formulation JSKN033

SUZHOU, China, March 26, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been dosed in Australia in the